MedPath

陕西方舟制药有限公司

Ownership
-
Established
1998-03-13
Employees
-
Market Cap
-
Website
http://www.sxark.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

54

NMPA:54

Drug Approvals

一清片

Approval Number
国药准字Z20090766
Approval Date
Jan 11, 2024
NMPA

阿胶当归胶囊

Approval Number
国药准字Z20080284
Approval Date
Dec 7, 2022
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H61021433
Approval Date
Feb 10, 2022
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H61021438
Approval Date
Feb 10, 2022
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H61021381
Approval Date
Feb 10, 2022
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H61020719
Approval Date
Feb 10, 2022
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H61021382
Approval Date
Feb 10, 2022
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H61020718
Approval Date
Feb 10, 2022
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H61020723
Approval Date
Feb 10, 2022
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H61020722
Approval Date
Feb 10, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath